Hi
Interesting. Seems, IMO, to be a good deal for shareholders. WES management have a good record of creating good, long term returns. So a small increase in the bid price is a sound possibility. If, as is my case, you own both WES and API, then this looks like a rare win-win situation - realise a gain on API and retain, albeit diluted within WES, future EPS from API.
Regards
Old Fisherman
Ann: WES:Proposal to acquire Australian Pharmaceutical Industries, page-4
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)